Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia Eckhardt

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Acta Neuropathologica Communications|January 16, 2024
Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impactRichard Drexler, Florian Brembach, Jennifer Sauvigny, et al.
Cancer Treatment and Research Communications|June 2, 2025
Epidermal growth factor receptor specific immunotherapy for SHH medulloblastoma tested in an in vitro blood-brain barrier-modelChristina Krüger, Petros Paplomatas, Naomé Kreuter, et al.
Neuro-Oncology|May 5, 2022
DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patientsFranz L Ricklefs, Richard Drexler, Kathrin Wollmann, et al.
Acta Neuropathologica|January 24, 2024
Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomasLara C Pohl, Maximilian Leitheiser, Denise Obrecht, et al.
Molecular Oncology|January 25, 2023
Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient diseaseMohamed E Elsesy, Su Jung Oh-Hohenhorst, Christoph Oing, et al.
Neuropathology and Applied Neurobiology|December 19, 2023
Molecular refinement of pilocytic astrocytoma in adult patientsHelena Bode, Catena Kresbach, Dörthe Holdhof, et al.
Neuro-Oncology Practice|September 18, 2023
Epigenetic profiling reveals a strong association between lack of 5-ALA fluorescence and <i>EGFR</i> amplification in <i>IDH</i>-wildtype glioblastomaRichard Drexler, Thomas Sauvigny, Ulrich Schüller, et al.
Acta Neuropathologica|September 10, 2024
Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significanceLotte Stegat, Alicia Eckhardt, Antonia Gocke, et al.
Neuro-Oncology|October 11, 2023
Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastomaAlicia Eckhardt, Richard Drexler, Melanie Schoof, et al.
Cancers|October 13, 2021
A Multi-Scale and Multi-Technique Approach for the Characterization of the Effects of Spatially Fractionated X-ray Radiation Therapies in a Preclinical ModelMariele Romano, Alberto Bravin, Alberto Mittone, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Acta Neuropathologica Communications|January 16, 2024
Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impactRichard Drexler, Florian Brembach, Jennifer Sauvigny, et al.
Cancer Treatment and Research Communications|June 2, 2025
Epidermal growth factor receptor specific immunotherapy for SHH medulloblastoma tested in an in vitro blood-brain barrier-modelChristina Krüger, Petros Paplomatas, Naomé Kreuter, et al.
Neuro-Oncology|May 5, 2022
DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patientsFranz L Ricklefs, Richard Drexler, Kathrin Wollmann, et al.
Acta Neuropathologica|January 24, 2024
Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomasLara C Pohl, Maximilian Leitheiser, Denise Obrecht, et al.
Molecular Oncology|January 25, 2023
Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient diseaseMohamed E Elsesy, Su Jung Oh-Hohenhorst, Christoph Oing, et al.
Neuropathology and Applied Neurobiology|December 19, 2023
Molecular refinement of pilocytic astrocytoma in adult patientsHelena Bode, Catena Kresbach, Dörthe Holdhof, et al.
Neuro-Oncology Practice|September 18, 2023
Epigenetic profiling reveals a strong association between lack of 5-ALA fluorescence and <i>EGFR</i> amplification in <i>IDH</i>-wildtype glioblastomaRichard Drexler, Thomas Sauvigny, Ulrich Schüller, et al.
Acta Neuropathologica|September 10, 2024
Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significanceLotte Stegat, Alicia Eckhardt, Antonia Gocke, et al.
Neuro-Oncology|October 11, 2023
Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastomaAlicia Eckhardt, Richard Drexler, Melanie Schoof, et al.
Cancers|October 13, 2021
A Multi-Scale and Multi-Technique Approach for the Characterization of the Effects of Spatially Fractionated X-ray Radiation Therapies in a Preclinical ModelMariele Romano, Alberto Bravin, Alberto Mittone, et al.
Pageof 2